Case Comprehensive Cancer Center

The Case Comprehensive Cancer Center (Case CCC), designated a comprehensive consortium cancer center by the National Cancer Institute (NCI) of the National Institutes of Health, has received a $25.5 million Cancer Center Support Grant from NCI. The renewal marks 38 years of continuous NCI funding,…

Continuing an esteemed family legacy of cancer science is no small feat—but Gary Schwartz, MD, carries on with aplomb. Case CCC's Director for two years, three months, and seven days (but who's counting), he was appointed the inaugural Peter and Laurie Weinberger Professorship in Cancer Research…

Educating the next generation of cancer researchers

Community-based prostate-cancer screening program teams up with barbershops Waverly Willis was out shopping with his daughter one day when he was blindsided—by a hug. A big, tearful, holding-on-for-dear-life hug, the kind that's usually reserved for long-distance airport arrivals and the…

A team of CWRU researchers penned an article titled “Fitness Seascapes are Necessary for Realistic Modeling of the Evolutionary Response to Drug Therapy,” which was recently published in Science Advances. Led by Eshan King, a student in the Medical Scientist Training Program at the School of…

New lymphoma T-cell therapy, made in less than a day, shows promising results with fewer side effects

Case Western Reserve University researchers combat deadly cancer with therapeutic vaccines

Despite our overcast climate, Northeast Ohioans still need to protect themselves from sun’s harmful rays

Co-leader of Case CCC's Immune Oncology Program, David Wald, MD, PhD, has already improved the landscape of CAR T immunotherapy by developing an ultra-fast procedure that cuts CAR T cell manufacturing from two weeks to less than 24 hours. However, harvesting T cells to make CAR T therapy…

A study, recently published in Proceedings of the National Academy of Sciences (PNAS) and co-led by Sanford Markowitz, MD, PhD, CWRU Distinguished University Professor and Case CCC Cancer Genomics and Epigenomics Program member, discovered that SW033291—a drug that was originally developed in the…